Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172


Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.

Do Y, Park CG, Kang YS, Park SH, Lynch RM, Lee H, Powell BS, Steinman RM.

Eur J Immunol. 2008 Jan;38(1):20-9.


Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor.

Do Y, Didierlaurent AM, Ryu S, Koh H, Park CG, Park S, Perlin DS, Powell BS, Steinman RM.

Vaccine. 2012 Oct 5;30(45):6359-67. doi: 10.1016/j.vaccine.2012.08.051. Epub 2012 Sep 1.


Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.

Do Y, Koh H, Park CG, Dudziak D, Seo P, Mehandru S, Choi JH, Cheong C, Park S, Perlin DS, Powell BS, Steinman RM.

Eur J Immunol. 2010 Oct;40(10):2791-6. doi: 10.1002/eji.201040511.


Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.

Shreewastav RK, Ali R, Uppada JB, Rao DN.

Cell Immunol. 2012 Jul-Aug;278(1-2):55-62. doi: 10.1016/j.cellimm.2012.07.002. Epub 2012 Jul 20.


The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.

Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM.

Ann N Y Acad Sci. 2009 Sep;1174:6-17. doi: 10.1111/j.1749-6632.2009.04933.x.


TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.

Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST.

Vaccine. 2010 Dec 16;29(2):357-62. doi: 10.1016/j.vaccine.2010.08.099. Epub 2010 Sep 15.


HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.

Batra L, Verma SK, Nagar DP, Saxena N, Pathak P, Pant SC, Tuteja U.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3322. doi: 10.1371/journal.pntd.0003322. eCollection 2014 Dec.


Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.

Trumpfheller C, Finke JS, López CB, Moran TM, Moltedo B, Soares H, Huang Y, Schlesinger SJ, Park CG, Nussenzweig MC, Granelli-Piperno A, Steinman RM.

J Exp Med. 2006 Mar 20;203(3):607-17. Epub 2006 Feb 27.


Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.

Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.

FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):215-29.


Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.

Wang S, Goguen JD, Li F, Lu S.

Vaccine. 2011 Sep 9;29(39):6802-9. doi: 10.1016/j.vaccine.2010.12.062. Epub 2011 Jan 1.


Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.

Stylianou E, Pepponi I, van Dolleweerd CJ, Paul MJ, Ma JK, Reljic R.

Vaccine. 2011 Mar 9;29(12):2279-86. doi: 10.1016/j.vaccine.2011.01.030. Epub 2011 Jan 25.


Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.

Miller NC, Quenee LE, Elli D, Ciletti NA, Schneewind O.

Infect Immun. 2012 Apr;80(4):1572-82. doi: 10.1128/IAI.05637-11. Epub 2012 Jan 17.


Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.

Gupta G, Khan AA, Rao DN.

Scand J Immunol. 2010 Mar;71(3):186-98. doi: 10.1111/j.1365-3083.2009.02365.x.


Yersinia pestis V protein epitopes recognized by CD4 T cells.

Parent MA, Berggren KN, Mullarky IK, Szaba FM, Kummer LW, Adamovicz JJ, Smiley ST.

Infect Immun. 2005 Apr;73(4):2197-204.


Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.

Uppada SB, Bhat AA, Sah A, Donthamshetty RN.

Vaccine. 2011 Nov 21;29(50):9352-60. doi: 10.1016/j.vaccine.2011.09.129. Epub 2011 Oct 12.


A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

Soares H, Waechter H, Glaichenhaus N, Mougneau E, Yagita H, Mizenina O, Dudziak D, Nussenzweig MC, Steinman RM.

J Exp Med. 2007 May 14;204(5):1095-106. Epub 2007 Apr 16.


Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.

Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, Rodriguez A, Clausen BE, Park CG, Trumpfheller C, Steinman RM.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2384-9. doi: 10.1073/pnas.1019547108. Epub 2011 Jan 24.


Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.

Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW.

Microb Pathog. 1997 Sep;23(3):167-79.


CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.

Njongmeta LM, Bray J, Davies CJ, Davis WC, Howard CJ, Hope JC, Palmer GH, Brown WC, Mwangi W.

Vaccine. 2012 Feb 21;30(9):1624-35. doi: 10.1016/j.vaccine.2011.12.110. Epub 2012 Jan 10.


Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.

Li B, Du C, Zhou L, Bi Y, Wang X, Wen L, Guo Z, Song Z, Yang R.

Clin Vaccine Immunol. 2012 Feb;19(2):228-34. doi: 10.1128/CVI.05559-11. Epub 2011 Dec 21.

Supplemental Content

Support Center